Gain strategic OTC real time contributions from sell side desks across money market, foreign exchange, commodities and energy, and equity.

Trading Bulletins for OTC Market

With revenues totaling approximately **** billion U.S. dollars, the cough and cold remedies segment was the largest segment in the U.S. OTC market, in 2023. This statistic shows the estimated distribution of the OTC (over-the-counter) market in the United States, by major segment.

The size of the OTC Market Europe market was valued at USD XX Million in 2024 and is projected to reach USD XXX Million by 2033, with an expected CAGR of 5.40% during the forecast period. Recent developments include: In March 2022, Cymbiotika launched an e-commerce store in the United Kingdom for its range of natural supplements aimed at boosting consumer vitality and longevity., In January 2022, P&G launched its highest strength Omega-3 under the Seven Seas brand in the United Kingdom.. Key drivers for this market are: Increasing Self-medication Practices, Increasing New Product Launches. Potential restraints include: High Probability of OTC Drug Abuse, Lack of Awareness. Notable trends are: Cough, Cold, and Flu Products Expected to Register High Growth.

This dataset is about stocks. It has 8,129 rows and is filtered where the exchange is OTC Markets Group. It features 8 columns including stock name, company, exchange, and exchange symbol.

The Over the Counter Drugs Market is Segmented by Product Type (Cough, Cold, and Flu, Analgesics, and More), Formulation Type (Tablets, Capsules and More), Distribution Channel (Hospital Pharmacies, Retail Chain Pharmacies, and More), Age Group (Pediatrics (0-14 Yrs), and More), Source (Chemical-Based and Herbal & Natural) and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

The general standard and public notice of stock information for the emerging board (TPEx).

The Europe Over-The-Counter (OTC) Drugs Market is Segmented by Product Type (Cough, Cold and Flu Products, and More), Formulation (Tablets and Caps, and More), Age Group (Pediatric (0-14 Yrs), and More), Sales Format (Branded, Generic, and Private-Label OTC), Distribution Channel (Hospital Pharmacies, and More), and Geography (Germany, United Kingdom, and More). The Market and Forecasts are Provided in Terms of Value (USD).

The historical sector stock trading price-to-volume ratio (OTC Market Center)

The global sales of Rx-to-OTC switches is estimated to be worth USD 43,008.6 million in 2025. The market is projected to grow at a CAGR of 5.0% and reach USD 70,056.5 million by 2035. The revenue generated by Rx-to-OTC switches in 2024 was USD 40,785.8 million where it demonstrated a year-on-year growth of 5.7%.

Attributes	Key Insights
Industry Size (2025E)	USD 43,008.6 million
Industry Value (2035F)	USD 70,056.5 million
CAGR (2025 to 2035)	5.0%

Semi Annual Market Update

Particular	Value CAGR
H1	5.3% (2024 to 2034)
H2	5.6% (2024 to 2034)
H1	5.0% (2025 to 2035)
H2	5.6% (2025 to 2035)

Country-wise Insights

Countries	Value CAGR (2025 to 2035)
United States	4.0%
Germany	5.0%
Japan	6.9%
China	6.6%
India	8.9%

Category-wise Insights

Drug Category	Value Share (2024)
Allergy and Respiratory	26.7%

Distribution Channel	Value Share (2024)
Retail Pharmacies	43.7%

From 2017 to 2022, the of OTC market of pharmacies in Poland had seen constant increase in value in the last year reaching ***** billion złoty. Whereas, the value of the OTC market of non-pharmacy stores reached **** billion złoty.

The OTC Drugs Market in India Report is Segmented by Product (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals, and Supplements [VMS], and Other Products) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channels). The Report Offers the Value (USD) for the Above Segments.

Technological advancements in the North America over the Counter Drugs (OTC) industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transforming industry practices, offering a comprehensive outlook on future opportunities and market potential.

Taiwan 60-Minute OHLCV Bars (TWSE & OTC)

Coverage: rolling window of the most recent ~60 calendar days (provider limit)

▶ Context 📝

This dataset provides intraday 60-minute OHLCV time-series for stocks listed on the Taiwan Stock Exchange (TWSE) and the Over-The-Counter (OTC) market. Data are scraped via yfinance using interval="60m". Yahoo Finance restricts intraday history to a recent window (~n days for <1d intervals), so the dataset reflects a rolling time horizon and cannot be extended further back via this source.

▶ Acknowledgements 🙏

• Data sourced from Yahoo Finance via the yfinance Python package.
• Stock metadata harvested from the TWSE ISIN service.

▶ Use Cases 💡

• Intraday strategy backtests on Taiwan equities (trend/momentum, breakout, mean-reversion)
• Liquidity/volume profiling and seasonality at hourly granularity
• Event-time studies around disclosures and market microstructure analysis

▶ Notes on Limits ⚠️

• History limit: Intraday history for interval="60m" is limited to roughly the last n days by the provider.
• Updates: Re-pull frequently (e.g., daily) to maintain a complete rolling window.

▶ Log 📰

• 27 Sep 2025: Initial 60-minute release — replaces prior daily dataset.

📊 Each CSV contains 60-minute bars with ISO-8601 timestamps (Asia/Taipei local market hours).

In 2023, vitamins dominated the over-the-counter (OTC) market in the Philippines at **** percent. This was followed by cough and cold preps, holding over ** percent of the market.

The Dermatological OTC Drugs Market report segments the industry into By Indication (Acne, Dermatitis, Psoriasis, Fungal Infections, Others), By Product (Tablets and Capsules, Oils, Gels, Creams, and Ointments, Others), By Route of Administration (Oral, Topical), By Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, Others), and Geography (North America, Europe, Asia-Pacific, and more).

The United Kingdom OTC Drugs Market Report is Segmented by Product Type (cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, and Other Product Types), Route of Administration (oral, Topical, and Parenteral), and Distribution Channel (retail Pharmacy, Hospital Pharmacy, and E-Pharmacy). The Report Offers the Value (in USD) for the Above Segments.

The report offers Pharma and OTC Market Dynamics, Comprises Industry development drivers, challenges, opportunities, threats and limitations. A report also incorporates Cost Trend of products, Mergers & Acquisitions, Expansion, Crucial Suppliers of products, Concentration Rate of Steel Coupling Economy. Global Pharma and OTC Market Research Report covers Market Effect Factors investigation chiefly included Technology Progress, Consumer Requires Trend, External Environmental Change.

List of stocks with the largest intraday decline in the OTC market (GreTai Securities Market)

The report covers Asia Pacific Over-the-Counter (OTC) Drugs Market size at USD 20 billion in 2023, featuring growth potential, key players, and industry trends shaping the market.